Mattress assemblies including antiviral protection

US11819136B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11819136-B2
Application numberUS-202117217313-A
CountryUS
Kind codeB2
Filing dateMar 30, 2021
Priority dateMar 31, 2020
Publication dateNov 21, 2023
Grant dateNov 21, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Antiviral-treated fabric layers for mattress assemblies includes a silver halide and liposome carrier. Additionally, the envelope encapsulating a cushioning material can include an antiviral-treated fabric. The antiviral-treated fabric can include silver halide and a liposome carrier, wherein the liposome carrier is a vesicle.

First claim

Opening claim text (preview).

What is claimed is: 1. A mattress assembly comprising: a ticking layer comprising a silver-based material on a user contact surface when the mattress assembly is in use, wherein the silver-based material comprises a plurality of vesicular carriers including silver ions disposed therein, wherein the vesicular is a cholesterin depleting lipid vesicle; and a base core layer, wherein the ticking layer overlies a top surface of the base core layer and defines an outermost surface of the mattress assembly. 2. The mattress assembly of claim 1 , wherein the silver based material comprises silver halide. 3. The mattress assembly of claim 1 , wherein the mattress assembly is a two-sided mattress. 4. The mattress assembly of claim 1 , wherein the mattress assembly is one-sided mattress. 5. The mattress assembly of claim 1 , wherein the ticking layer comprises a fabric covering, wherein at least a portion of the fabric covering or fibers defining the fabric covering comprise the silver-based material. 6. The mattress assembly of claim 1 , further comprising a base core layer comprising an innerspring assembly, wherein the ticking layer overlies the base core layer. 7. The mattress assembly of claim 1 , further comprising a base core layer comprising one or more foam layers, wherein the ticking layer overlies the base core layer. 8. The mattress assembly of claim 1 , wherein the silver-based material is in a range of about 5 to about 20 percent by weight of fabric. 9. A mattress assembly, comprising, a base core having an upper primary surface, a mattress panel overlying the upper primary surface of the base core comprising, an antiviral-treated fabric layer comprising a silver-based material including a plurality of vesicular carriers including silver ions disposed therein, wherein the vesicular carrier is a cholesterin depleting lipid vesicle, and a filler layer disposed below the fabric layer, wherein the fabric layer, and filler layer are joined at a respective edge. 10. The mattress assembly of claim 9 , further comprising a fire resistant layer within the mattress panel intermediate the filler layer and the antiviral-treated fabric layer and being joined at the respective edge. 11. The mattress assembly of claim 9 , further comprising a backing layer underlying the filler layer and being joined at the respective edge. 12. The mattress assembly of claim 11 , wherein at least two of the fabric layer, filler layer, and backing layer are joined together by stitching, gluing, stapling, tying, or melting. 13. The mattress assembly of claim 9 , wherein the base core comprises a core selected from the group of innersprings, pocketed innersprings, viscoelastic foam, latex foam, polyurethane foam and combinations thereof. 14. The mattress assembly of claim 9 , wherein the mattress panel is configured to be removable from the mattress assembly. 15. The mattress assembly of claim 9 , wherein the mattress panel comprises a comforter. 16. The mattress assembly of claim 9 , wherein the silver-based material is in a range of about 5 to about 20 percent by weight of fabric layer. 17. The mattress assembly of claim 9 , wherein the mattress panel comprises a mattress protector.

Assignees

Inventors

Classifications

  • A47C31/007Primary

    Anti-mite, anti-allergen or anti-bacterial means · CPC title

  • Mattress or cushion tickings or covers · CPC title

  • with foamed material inlays · CPC title

  • comprising deodorising, fragrance releasing, therapeutic or disinfecting substances · CPC title

  • Pillows (pillow holders A47C21/00, {A47C21/026}; specially adapted for preventing snoring A61F5/56) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11819136B2 cover?
Antiviral-treated fabric layers for mattress assemblies includes a silver halide and liposome carrier. Additionally, the envelope encapsulating a cushioning material can include an antiviral-treated fabric. The antiviral-treated fabric can include silver halide and a liposome carrier, wherein the liposome carrier is a vesicle.
Who is the assignee on this patent?
Dreamwell Ltd
What technology area does this patent fall under?
Primary CPC classification A47C31/007. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).